Table 2.
Ref. | Method | Regimen | Patient population | No. of files (cases) | Sampling times investigated (h) | Suggested times of LSS (h) | Predicted AUC = | r2 | LSS validation | Bias | Precision |
Attard et al[78] | EMIT or | CsA or TAC | Pediatrics | 41 files | 0, 0.33, 0.67, 1.25, 2, 4, 6, 8 | 0, 0.33, 2 | 9.1 + 5.7*C0h + 1.1*C0.33h + 2.1*C2h | 0.740 | No | N/A | N/A |
HPLC-UV | + MMF | (41 cases) | 0, 0.67, 6 | 5.2 + 7.1*C0h + 1.1*C0.66h + 5.4*C6h | 0.880 | No | N/A | N/A | |||
Chen et al[71] | HPLC | TAC + MMF | Adults | 72 files | 0.5, 1, 1.5, 2, 4, 6, 8, 10, 12 | 1, 2, 4 | 10.776 + 0.749*C1h + 1.604*C2h + 4.116*C4h | 0.750 | Validation | Yes | Yes |
(40 cases) | 1, 2, 6 | 10.229 + 0.925*C1h + 1.750*C2h + 4.586*C6h | 0.855 | Group | Yes | Yes | |||||
1, 2, 6, 8 | 5.503 + 0.919*C1h + 1.871*C2h + 3.176*C6h + 3.664*C8h | 0.921 | Yes | Yes | |||||||
1, 2, 4, 6 | 6.658 + 0.921*C1h + 1.573*C2h + 2.057*C4h + 3.543*C6h | 0.899 | Yes | Yes | |||||||
Chen et al[76] | EMIT | TAC + MMF | Adults | 48 files | 0.5, 1, 1.5, 2, 4, 6, 8, 10, 12 | 1.5, 6 | 10.56 + 1.55C1.5h + 6.44C6h | 0.859 | Bootstrap | Yes | Yes |
(48 cases) | 2, 4, 8 | 9.37 + 2.18C2h + 2.10C4h + 4.71C8h | 0.901 | Yes | Yes | ||||||
1, 2, 4, 8 | 4.46 + 0.81C1h + 1.78C2h + 2.51C4h + 4.94C8h | 0.950 | Yes | Yes | |||||||
1, 2, 4, 6 | 5.92 + 1.10C1h + 1.01C2h + 1.77C4h + 4.80C6h | 0.927 | Yes | Yes |
LSS: Limited sampling strategy; MPA: Mycophenolic acid; AUC: Area under the concentration-time curve; EMIT: Enzyme multiplied immunoassay technology; HPLC: High-performance liquid chromatography; TAC: Tacrolimus; MMF: Mycophenolate mofetil; CsA: Cyclosporine A.